Prescriber Scope of Practice for Depression in California

If you’re a psychiatrist or PMHNP managing depression via telehealth, you’re navigating a regulatory landscape that’s changed more in the past five years than it did in the previous twenty. The good news? The current rules are remarkably provider-friendly—especially if you know where the landmines are.

Let’s cut through the noise and talk about what actually matters: Can you prescribe antidepressants via telehealth? What about controlled substances for co-occurring conditions? And how do state laws differ if you’re treating patients in California versus Texas or Florida?

This guide walks through the federal DEA rules (which were just extended through 2026), state-by-state prescribing laws for our priority markets, and the scope-of-practice differences between psychiatrists and PMHNPs that directly impact how you can practice.

The Federal Baseline: DEA Telehealth Rules Through 2026

Here’s what you need to know right now:

The DEA and HHS just announced (January 2026) a fourth extension of COVID-era telehealth flexibilities through December 31, 2026. This means you can continue prescribing controlled substances—including Schedule II stimulants for ADHD or benzodiazepines for anxiety—via telehealth to new patients without requiring an initial in-person exam.

This is a massive deal for psychiatric practice. Under normal circumstances, the Ryan Haight Act (passed in 2008 to prevent online pill mills) requires an in-person medical evaluation before prescribing any controlled substance via telemedicine. But that requirement has been suspended since March 2020, and the DEA keeps extending the suspension because Congress and provider groups have been clear: forcing psychiatric patients back to in-person visits would create a care access crisis.

What this means for depression treatment:

Most first-line depression medications—SSRIs, SNRIs, bupropion, mirtazapine—are non-controlled substances, so they were never subject to the Ryan Haight in-person rule. You can prescribe these via telehealth in any state as long as you meet the standard of care (proper evaluation, documentation, informed consent).

The DEA flexibilities matter when you’re managing comorbid conditions that require controlled substances:

• A patient with major depression and severe anxiety might need a benzodiazepine (Schedule IV)
• A treatment-resistant depression case might benefit from adjunctive stimulant therapy (Schedule II)
• A depressed patient with ADHD might need Adderall or Ritalin (Schedule II)
• A patient with insomnia related to depression might need a sleep aid like zolpidem (Schedule IV)

Under the current extension, all of these scenarios are legally manageable via telehealth, provided you’re meeting standard-of-care requirements (thorough evaluation, PDMP checks, appropriate monitoring, documentation).

What’s coming next:

The DEA is working on permanent rules to replace these temporary extensions. In January 2025, they proposed a new ‘Special Registration for Telemedicine’ system that would allow certain providers to prescribe controlled substances via telehealth without in-person visits:

• For Schedule III-V drugs, any provider could apply for a telemedicine special registration
• For Schedule II drugs (the most tightly controlled—stimulants, opioids), only certain specialists would qualify for an ‘Advanced Telemedicine Prescribing’ registration
• Psychiatrists (MD/DO) are explicitly included in the specialist list for Schedule II telehealth prescribing
• PMHNPs are not specifically mentioned in the proposed Schedule II rules, which could create a scope-of-practice gap if finalized as written

The DEA is soliciting public comments on these proposals through early 2026, and final rules are expected by late 2026. Until then, the current flexibilities remain in place.

Bottom line for your practice:

Right now (through end of 2026), you can manage depression and related psychiatric conditions entirely via telehealth, including prescribing controlled substances for comorbid anxiety, ADHD, or insomnia. Document thoroughly, check state PDMPs, use secure video platforms, and follow all other standard prescribing requirements—but don’t let the Ryan Haight Act stop you from treating patients who need medication management remotely.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Psychiatrists vs PMHNPs: Scope of Practice for Depression Treatment

Your scope of practice determines not just what you can prescribe, but how independently you can practice—and this varies dramatically by state if you’re a PMHNP.

Psychiatrists (MD/DO): Full Authority, Minimal Restrictions

As a psychiatrist, your scope for treating depression is essentially unrestricted:

• You can diagnose and treat any mental health condition
• You can prescribe any medication (controlled or non-controlled) within your clinical judgment
• You can practice independently in all 50 states (no supervision required)
• You have full prescriptive authority for Schedule II-V controlled substances with a DEA registration

The regulatory requirements you face are the same as any other physician specialty: proper licensure in each state where you practice, DEA registration for controlled substances, standard-of-care compliance, and following any state-specific prescribing rules (like checking prescription monitoring databases).

For telehealth, you must be licensed in the state where the patient is located at the time of the consultation. Some states make this easier:

• Interstate Medical Licensure Compact (IMLC) states allow streamlined licensing if you qualify (currently includes Texas, Pennsylvania, Illinois, and 36 other states)
• Florida offers an out-of-state telehealth registration option (cheaper and faster than full licensure)
• States like California and New York require full state licensure with no shortcuts

One emerging consideration: the DEA’s proposed permanent rules would give psychiatrists explicit authority to prescribe Schedule II drugs via telehealth through the ‘Advanced Telemedicine Prescribing’ registration. This essentially formalizes what’s already happening under the temporary flexibilities and protects psychiatric telehealth practice long-term.

PMHNPs: State-by-State Variability

If you’re a psychiatric mental health nurse practitioner, your scope of practice is determined by state nurse practice acts, which vary wildly:

Full Practice Authority (FPA) States:

In states with FPA, experienced PMHNPs can practice completely independently—no physician supervision, no collaborative agreements, full prescriptive authority.

• California: As of January 2024, qualified NPs (≥3 years experience) can obtain ‘104 NP’ status and practice independently statewide in their specialty area. This was a game-changer—California historically required physician supervision but AB 890 (passed 2020) finally allowed NP independence.

• New York: Experienced NPs (≥3,600 hours of practice) can practice without written collaborative agreements or physician oversight as of 2022. The state made permanent the Nurse Practitioners Modernization Act provisions.

• Illinois: PMHNPs can apply for Full Practice Authority after 4,000 hours of collaborative practice plus additional education. Once approved, they can prescribe all medications including controlled substances independently (with a consultation requirement for long-term Schedule II opioid prescribing, but that rarely applies to psychiatric practice).

In these states, a PMHNP can join a telehealth platform, see patients, diagnose depression, prescribe SSRIs or benzodiazepines, and manage care entirely on their own. This is the model that makes the most sense economically—you’re not paying a psychiatrist to supervise you or navigate collaboration agreements.

Restricted Practice States:

Other states still require PMHNPs to practice under some degree of physician oversight:

• Texas: All APRNs must have a Prescriptive Authority Agreement with a physician. The physician and NP must meet at least monthly to discuss complex cases. This is non-negotiable—you cannot prescribe without a supervising physician, even via telehealth.

• Florida: Despite passing an NP autonomy law in 2020, it excluded psychiatric NPs. Only primary care NPs (family medicine, internal medicine, pediatrics) can practice independently. PMHNPs must have a supervising physician and signed protocol agreement.

• Pennsylvania: No FPA legislation has passed. PMHNPs need a collaborative agreement with a physician (usually a psychiatrist) to prescribe medications. Bills to change this have repeatedly stalled in the legislature.

What this means for controlled substance prescribing:

Even in states requiring collaboration, PMHNPs typically can prescribe non-controlled antidepressants once the collaborative agreement is in place. For controlled substances, rules vary:

• Many states allow NPs to prescribe Schedule III-V under collaboration
• Schedule II prescribing is more restricted—some states limit it to hospital settings or require the physician’s direct involvement
• Illinois’s FPA NPs can prescribe Schedule II independently; Texas NPs generally cannot prescribe Schedule II in outpatient telepsych
• The proposed DEA rules might limit Schedule II telehealth prescribing to psychiatrists, which could affect PMHNP practice even in FPA states

The reality check:

If you’re a PMHNP, research your state’s practice authority before committing to a telehealth platform. In FPA states, you can operate like a psychiatrist (minus the MD designation). In restricted states, you’ll need a collaborating psychiatrist—which might be arranged through the platform, but it adds administrative complexity and potentially reduces your take-home pay.

For Klarity and similar platforms, this means some states are easier to recruit PMHNPs into than others. Highlighting which states allow independent practice is crucial for PMHNP recruitment content.

State-by-State Prescribing Rules: Where the Rubber Meets the Road

Federal DEA rules set the floor, but states can add their own requirements for telehealth prescribing. Here’s what matters in our priority states:

California: Wide Open for Telehealth

The setup:

• No state law requiring an in-person exam before prescribing via telehealth
• Telehealth encounters can establish a valid patient relationship if they meet standard of care
• Strong telehealth parity laws requiring insurers to cover tele-mental health equivalent to in-person
• During COVID, California even allowed audio-only mental health visits (though video is preferred)

For psychiatrists:

• You need a full California medical license (CA is NOT in the Interstate Compact)
• No special telehealth restrictions beyond standard of care
• Controlled substances can be prescribed via telehealth following federal rules
• Must check California’s CURES prescription monitoring program for controlled substance prescriptions

For PMHNPs:

• AB 890 created a pathway to independent practice (effective 2023-2024)
• Experienced PMHNPs (≥3 years) can become ‘104 NPs’ and practice fully independently, including via telehealth
• This is recent—many California PMHNPs are still in the transition process
• Once you have 104 status, you have the same prescriptive authority as a psychiatrist for depression management

Market context:California has a large provider shortage in rural and inland areas despite having many psychiatrists overall. Telepsychiatry is mainstream—major health systems like Kaiser use it extensively. The recent NP independence law signals California is prioritizing access expansion.

Texas: Permissive for Psychiatric Practice, But Watch the Details

The setup:

• Texas modernized its telehealth laws in 2017 (SB 1107), allowing patient relationships to be established via video without in-person visits
• Telehealth must use live audio-visual technology for new patients (phone-only is insufficient)
• Texas has specific rules prohibiting telemedicine for chronic pain management with controlled substances—but this doesn’t apply to psychiatric conditions

The chronic pain exception:Texas Medical Board rules explicitly prohibit treating chronic pain with controlled substances via telemedicine unless the patient has been seen in-person within 90 days or meets specific exceptions. This is aimed at preventing telehealth opioid prescribing for pain management.

What this means for depression providers:

• You can absolutely prescribe antidepressants, anxiety medications, ADHD stimulants via telehealth
• The chronic pain rule doesn’t stop you from managing depression, anxiety, or ADHD with controlled substances
• If you have a patient with comorbid chronic pain and depression, be cautious—document that your controlled substance prescribing is for psychiatric conditions, not pain management

For psychiatrists:

• Need a full Texas medical license (though Texas IS in the IMLC, making multi-state licensing easier)
• No prohibition on psychiatric controlled substance prescribing via telehealth
• Must use video for new patient evaluations

For PMHNPs:

• Texas requires a Prescriptive Authority Agreement with a physician—no exceptions
• The supervising physician must be Texas-licensed and available for consultation
• Monthly meetings/case reviews are required by law
• Schedule II prescribing is severely limited for NPs in Texas (mostly restricted to inpatient settings)
• If you’re managing ADHD with stimulants via telehealth in Texas as an NP, you’ll likely need the supervising psychiatrist to prescribe Schedule IIs

Market context:Texas has 246 of 254 counties designated as mental health shortage areas. The state needs telepsychiatry desperately, which is why they opened up telemedicine laws. But they maintain tight control over NP independence and opioid prescribing, reflecting conservative regulatory attitudes.

Florida: Surprisingly Friendly for Tele-Psychiatry

The setup:

• Florida Statute 456.47 allows out-of-state providers to register to provide telehealth in Florida (renewable every 2 years)
• This is huge—you don’t need a full Florida license if you’re licensed elsewhere; just register for telehealth
• Florida has a specific carve-out for psychiatric prescribing of controlled substances

The Schedule II exception:Florida law prohibits prescribing Schedule II controlled substances via telehealth except for:

1. Psychiatric disorders
2. Inpatient hospital treatment
3. Hospice care
4. Nursing home residents

This means as a psychiatrist treating depression, you can prescribe Adderall, Ritalin, or other Schedule II medications via telehealth to Florida patients as long as it’s part of psychiatric treatment (for ADHD, treatment-resistant depression, etc.). This is explicitly permitted by statute.

Schedule III-V medications can be prescribed via telehealth without these restrictions.

For psychiatrists:

• Either get a full Florida license OR use the out-of-state telehealth registration (cheaper/faster)
• Schedule II psychiatric prescribing is allowed—document the psychiatric indication clearly
• Must check Florida’s E-FORCSE prescription monitoring program
• Florida participates in IMLC if you want a full license

For PMHNPs:

• Florida’s 2020 NP autonomy law excluded psychiatric NPs—only primary care NPs can practice independently
• PMHNPs must have a Florida supervising physician and signed protocol agreement
• Even with out-of-state telehealth registration, you need that Florida physician collaboration
• This makes Florida more challenging for NP recruitment unless you can pair them with supervising psychiatrists

Market context:Florida’s large and growing population combined with provider shortages makes it attractive for telehealth. The psychiatric exception for Schedule II prescribing shows the state recognizes the importance of tele-mental health access. But the NP restriction is frustrating—many PMHNPs are left out of the independence movement here.

New York: Progressive and Supportive

The setup:

• Strong telehealth parity laws predating COVID
• No in-person exam requirement for prescribing via telehealth
• Explicit allowance for audio-only mental health visits (extended for behavioral health Medicaid)
• Mandatory e-prescribing for all medications

For psychiatrists:

• Need a full New York license (NY is NOT in IMLC)
• No special telehealth prescribing restrictions
• Follow federal DEA rules for controlled substances
• Must use New York’s PMP Registry integration for e-prescribing controlled substances

For PMHNPs:

• Experienced NPs (≥3,600 hours) can practice completely independently since 2022
• No written collaborative agreement required once you hit that threshold
• This is real independence—you can run your own telehealth practice without a supervising MD
• Full prescriptive authority including controlled substances (following DEA rules)

Market context:New York has a concentration of providers in NYC but significant shortages upstate. Telepsychiatry programs connecting city specialists to rural patients are common. The state actively encourages tele-mental health to improve access. New York’s NP independence law is one of the strongest in the country.

Pennsylvania: Telehealth-Friendly Despite Lack of Formal Statute

The setup:

• No comprehensive telehealth statute (legislation has repeatedly failed)
• However, the Department of State confirms telehealth is permissible if it meets standard of care
• Practitioners can deliver care via telemedicine under existing authority
• No state-level prohibition on controlled substance prescribing via telehealth (defers to federal rules)

For psychiatrists:

• Need a full Pennsylvania license (though PA IS in IMLC since 2021)
• Telehealth evaluation sufficient to prescribe if proper standard of care is met
• Mandatory e-prescribing for controlled substances
• Must check Pennsylvania’s PDMP before prescribing controlled substances

For PMHNPs:

• No full practice authority—collaborative agreement with a physician is required
• The agreement must be filed with the PA Board of Nursing
• Physician doesn’t need to be present during telehealth sessions but must be available for consultation
• Bills to grant NP independence (like SB 25) have not passed as of 2025

Market context:Pennsylvania has large rural areas with severe psychiatrist shortages. Telepsychiatry is a lifeline for these communities—state agencies actively reimburse telehealth equivalent to in-person under Medicaid. The lack of a formal telehealth law creates some uncertainty, but in practice, PA is permissive. Always obtain explicit patient consent for telehealth and document it.

Illinois: Clear Rules, Strong Support

The setup:

• Illinois passed a comprehensive Telehealth Expansion Act in 2021 (effective 2022)
• Insurance parity for telehealth required
• No in-person exam mandate—telehealth exam valid for prescribing
• Explicitly allows telehealth from any location, including patient home
• Audio-only sessions allowed for behavioral health when appropriate

For psychiatrists:

• Need Illinois license (IL is in IMLC for streamlined multi-state licensing)
• No special telehealth prescribing restrictions
• Follow federal rules for controlled substances
• Use Illinois’s Prescription Monitoring Program
• Mandatory e-prescribing for controlled substances

For PMHNPs:

• Full Practice Authority (FPA) available after 4,000 hours of collaborative practice plus additional education/training
• PMHNPs with FPA can practice and prescribe completely independently
• Must apply to Illinois Department of Professional Regulation for independent practice license
• With FPA, you can prescribe all medication schedules including Schedule II (with physician consultation requirement for long-term high-dose opioids, rarely applicable in psych)
• Without FPA, a collaborative agreement with a physician is required

Market context:Illinois has most providers concentrated in Chicago, leaving downstate rural areas underserved. The 2021 telehealth law was landmark legislation that firmly established telehealth as equivalent to in-person care. Illinois also has strong health equity guidelines—the state wants telehealth used to increase access, not create barriers.

State Comparison Table: Quick Reference

The Economics: Why Telehealth Prescribing Rules Matter to Your Bottom Line

Understanding these regulations isn’t just about compliance—it directly impacts your earning potential and practice growth.

The traditional marketing cost problem:

If you’re building a practice from scratch, patient acquisition is expensive:

• SEO takes 6-12 months of consistent investment before generating meaningful patient flow—and most solo providers don’t have the expertise to do it themselves
• Google Ads for mental health keywords cost $15-40+ per click, and most clicks don’t convert to booked patients—realistic cost per booked patient is $200-400+ when you factor in testing, optimization, and no-shows
• Directory listings (Psychology Today, Zocdoc) charge monthly fees AND you compete with hundreds of other providers—Zocdoc charges per booking ($35-100+) plus subscription costs
• DIY marketing can eventually be cost-effective if you have the budget, expertise, and patience—but most providers, especially those starting out or scaling, don’t want to gamble $3,000-5,000/month on uncertain results

Why telehealth-friendly regulations increase your addressable market:

If you can practice via telehealth across multiple states, you’re not limited to your local market. A psychiatrist with licenses in California, Texas, and Florida can potentially serve patients across 100+ million people. The economics improve dramatically:

• Larger patient pool means less reliance on expensive local marketing
• Platform-based practices (like Klarity) can aggregate demand across states and match you with pre-qualified patients
• You pay only when you see patients (no upfront marketing spend, no wasted ad budget on clicks that don’t convert)

The state-by-state calculation:

States with clear, permissive telehealth rules are lower-risk for providers:

• California, Illinois, New York: Clear laws, strong parity requirements, established telehealth infrastructure
• Florida, Texas: Permissive for psychiatric practice but with specific restrictions to navigate
• Pennsylvania: Less formally defined but practically permissive

States requiring collaborative agreements for PMHNPs create administrative friction but don’t necessarily reduce earning potential—you just need the right setup (platform provides supervising psychiatrist, agreements are standardized, etc.).

The platform advantage:

Instead of spending months building SEO, testing ad campaigns, and hoping patients call, platforms that handle patient acquisition remove the risk entirely:

• Pre-qualified patients already matched to your specialty and availability
• No wasted spend on leads that don’t convert
• Built-in telehealth infrastructure (no separate platform costs)
• Both insurance and cash-pay patient flow
• You control your schedule—only pay when you see patients

The key is choosing states where telehealth regulations make practice straightforward. If you’re a PMHNP in a restricted state, factor in the cost/complexity of maintaining a collaborative agreement. If you’re a psychiatrist, prioritize states where you can get licensed easily (IMLC states, Florida’s telehealth registration).

Staying Compliant While Maximizing Revenue

The non-negotiables for telehealth prescribing:

1. Proper licensure in every state where you treat patients (or valid telehealth registration in Florida)

2. DEA registration in each state where you prescribe controlled substances (required even for telehealth)

3. Standard-of-care evaluations: Video visits must include a thorough psychiatric assessment—history, mental status exam, risk assessment, diagnosis, treatment plan

4. PDMP checks: Most states require checking the prescription monitoring database before prescribing controlled substances, even via telehealth

5. Electronic prescribing: Many states mandate e-prescribing for controlled substances (PA, IL, NY, etc.)

6. Informed consent: Document patient consent for telehealth services, including understanding of technology limitations and emergency protocols

7. Documentation: Chart notes must meet the same standards as in-person visits—if anything, be more thorough to demonstrate appropriate evaluation occurred

Emerging compliance considerations:

• Platform registration: The DEA’s proposed permanent rules would require telehealth companies/platforms to register with DEA—make sure any platform you work with is prepared for this

• Special telemedicine registration: If finalized as proposed, you may need to apply for DEA special registration to continue prescribing certain controlled substances via telehealth after 2026—psychiatrists are explicitly included for Schedule II

• State board audits: As telehealth grows, state medical and nursing boards are increasing scrutiny—maintain excellent documentation

The red flags that trigger problems:

• Prescribing based solely on questionnaires without a live video consultation
• Failing to check PDMP before prescribing controlled substances
• Prescribing controlled substances across state lines without proper licensure
• Inadequate documentation of telehealth encounters
• Not having emergency protocols in place for acutely suicidal patients on video

What This Means for Your Practice

If you’re a psychiatrist:

You have maximum flexibility. The current regulatory environment allows you to:

• Treat depression and related conditions entirely via telehealth in all 50 states (if licensed)
• Prescribe any necessary medications including controlled substances
• Practice without supervision or collaborative agreements
• Access the proposed DEA ‘Advanced Telemedicine Prescribing’ registration for long-term Schedule II prescribing

Your main decision points are which states to get licensed in (prioritize IMLC states for ease) and whether to build your own practice or join a platform that handles patient acquisition.

If you’re a PMHNP:

Your scope varies by state, so you need to be strategic:

• In FPA states (California, New York, Illinois once approved), you can practice like a psychiatrist—full independence, full prescriptive authority
• In restricted states (Texas, Florida, Pennsylvania), you need a collaborating physician—factor this into your practice economics

The trajectory is toward more independence—multiple states have passed or are considering FPA legislation. But for now, if you’re starting a telehealth practice, prioritize states where you can practice independently or ensure your platform handles collaboration agreements seamlessly.

If you’re considering a telehealth platform:

The right platform eliminates the biggest pain points:

• No need to build your own marketing and worry about $200-500 patient acquisition costs
• Pre-qualified patient flow from day one
• Telehealth infrastructure already built and compliant
• For PMHNPs in restricted states, collaboration agreements handled administratively
• Standard listing fee per patient instead of gambling on marketing spend

The key questions to ask:

1. Which states can I practice in through the platform?
2. If I’m an NP in a restricted state, do you provide collaborating physicians?
3. What’s included in the listing fee? (platform, EHR, prescribing tools, billing support?)
4. What types of patients will I see? (depression-focused, or broader psychiatric conditions?)
5. How much control do I have over my schedule?

FAQs: Telehealth Prescribing for Depression Providers

Can I prescribe antidepressants via telehealth to new patients I’ve never met in person?

Yes, in all states. SSRIs, SNRIs, bupropion, and other non-controlled antidepressants have never been subject to in-person exam requirements. As long as you conduct an appropriate evaluation via video (or audio where permitted) that meets the standard of care, you can prescribe.

Can I prescribe controlled substances like benzodiazepines or stimulants via telehealth?

Yes, under current federal rules (extended through December 31, 2026). The DEA’s COVID-era flexibilities allow prescribing Schedule II-V controlled substances via telehealth without an initial in-person exam. After 2026, new rules will likely require a special DEA registration but will continue to permit psychiatric telehealth prescribing, especially for psychiatrists.

Do I need a separate license in every state where I see patients via telehealth?

Generally yes. You must be licensed in the state where the patient is located at the time of the consultation. Exceptions: Florida offers an out-of-state telehealth registration. Interstate compacts (IMLC for physicians) streamline getting licenses in multiple states.

What’s the difference between practicing as a psychiatrist vs PMHNP for telehealth depression treatment?

Psychiatrists have full independent practice authority and prescriptive authority in all states. PMHNPs have varying scope depending on the state—full independence in California, New York, and Illinois (if qualified), but require physician collaboration in Texas, Florida, and Pennsylvania. The clinical work is similar; the difference is administrative/legal setup.

Can I use phone-only (audio-only) sessions for prescribing?

It depends on the state. Many states allowed audio-only during COVID for behavioral health and some have extended this (like New York for Medicaid). However, most states expect video for new patient evaluations when prescribing. Always check state-specific rules and document why video wasn’t used if you prescribe based on audio-only.

What happens after the DEA telehealth flexibilities expire in December 2026?

The DEA is working on permanent rules that will likely create a special registration system for telemedicine prescribing of controlled substances. Psychiatrists are expected to be explicitly authorized to continue prescribing Schedule II medications via telehealth. PMHNPs’ scope under the new rules is less clear—stay tuned for final regulations.

Can I prescribe Adderall or Ritalin (Schedule II stimulants) for ADHD via telehealth?

Yes, under current federal rules through 2026. State-specific rules apply: Florida explicitly permits Schedule II prescribing for ‘psychiatric disorders’ via telehealth. Texas doesn’t prohibit it for psychiatric conditions (only for chronic pain). California, New York, Pennsylvania, and Illinois defer to federal rules. Always document the psychiatric indication clearly.

Do state telehealth laws apply if I’m prescribing non-controlled medications?

Less so. Most state telehealth restrictions focus on controlled substances. For non-controlled prescriptions, the main requirements are establishing a valid patient relationship (usually via video) and meeting standard of care. But you still need to be licensed in the patient’s state.

How do I know if I’m meeting ‘standard of care’ for a telehealth psychiatric evaluation?

A proper telehealth evaluation for depression should include: detailed psychiatric history, current symptoms and severity (consider using PHQ-9), past treatment history, mental status examination via video, suicide risk assessment, substance use screening, relevant medical history, discussion of treatment options, informed consent for telehealth, and emergency contact/safety planning. Document everything as you would in-person, or more thoroughly.

Can platforms like Klarity handle the collaborative agreement requirement for PMHNPs in restricted states?

Many platforms can facilitate this by connecting PMHNPs with collaborating psychiatrists who serve as the supervising physician of record. The specifics depend on state law—some states require monthly meetings, chart reviews, etc. Ask the platform how they structure collaborations and whether there’s additional cost to you.

Ready to Practice Telepsychiatry Without the Regulatory Headaches?

The regulatory landscape for telehealth prescribing is more favorable than it’s been in decades—and it’s likely to stay that way. The DEA has extended flexibilities through 2026, states are increasingly adopting NP independence laws, and insurance parity for telehealth is now standard.

But navigating 50 different state laws, managing multi-state licensure, and building a patient base from scratch is still daunting.

Klarity Health removes these barriers:

• Pre-qualified patients across multiple states matched to your specialty (no DIY marketing, no patient acquisition costs)
• Clear state-by-state guidance on what you can prescribe and whether you need collaboration (we handle the setup)
• Pay-per-appointment model (no upfront marketing spend—you only pay when you see patients)
• Built-in telehealth platform with integrated EHR, e-prescribing, and compliance tools
• Both insurance and cash-pay patients for steady, diversified income

If you’re a psychiatrist or PMHNP ready to expand your depression-focused telehealth practice without gambling thousands on marketing or spending months navigating state regulations, explore Klarity’s provider network.

See how Klarity’s platform works and whether your state qualifications make you eligible to join our network of psychiatric providers treating depression patients across the country.

References

1. U.S. Department of Health and Human Services. ‘HHS and DEA Extend Telemedicine Flexibilities for Prescribing Controlled Medications Through 2026.’ January 2, 2026. https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html

2. U.S. Drug Enforcement Administration. ‘DEA Announces Three New Telemedicine Rules to Continue Open Access to Telehealth While Establishing New Patient Protections.’ January 16, 2025. https://www.dea.gov/press-releases/2025/01/16/dea-announces-three-new-telemedicine-rules-continue-open-access

3. Florida Legislature. Florida Statutes §456.47 – ‘Use of Telehealth to Provide Services.’ Accessed January 2026. [https://www.leg.state.fl.us/statutes/index.cf

Source:

• https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html#:~:text=announced%20a%20fourth%20temporary%20extension,disruptions%20in%20care%20while%20permanent
• https://www.dea.gov/press-releases/2025/01/16/dea-announces-three-new-telemedicine-rules-continue-open-access#:~:text=registration%20is%20available%20to%20medical,V%20medications
• https://www.dea.gov/press-releases/2025/01/16/dea-announces-three-new-telemedicine-rules-continue-open-access#:~:text=These%20rules%20are%20a%20result,temporary%20rule%20until%20December%202025
• https://www.dea.gov/press-releases/2025/01/16/dea-announces-three-new-telemedicine-rules-continue-open-access#:~:text=is%20accessible%20for%20medical%20care,is%20being%20prescribed%20controlled%20medication
• https://www.rn.ca.gov/practice/ab890.shtml#:~:text=%2A%20103%20NP%20,focus%20of%20their%20National%20Certification
• https://www.rivkinrounds.com/2022/04/new-law-allows-experienced-nps-to-practice-independently-in-ny/#:~:text=New%20York%20law%20previously%20allowed,based%20on%20only
• https://txrules.elaws.us/rule/title22chapter174sec.174.5#:~:text=,person%20setting
• https://txrules.elaws.us/rule/title22chapter174sec.174.5#:~:text=,be
• https://www.leg.state.fl.us/statutes/index.cfm?Appmode=DisplayStatute&URL=0400-0499%2F0456%2FSections%2F0456.47.html#:~:text=telehealth%20to%20provide%20health%20care,in%20Schedule%20II%20of%20s
• https://txrules.elaws.us/rule/title22chapter174sec.174.5#:~:text=,through%20a%20telemedicine%20medical%20service